-

$undefined

N/A

(N/A)

Coya Therapeutics :COYA

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

76.04M

Cash

31.06M

Avg Qtr Burn

-2.53M

Short % of Float

2.02%

Insider Ownership

7.04%

Institutional Own.

26.72%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
COYA 301 [Low Dose Interleukin-2 (LD IL-2)] Details Alzheimer's disease, Neurodegenerative disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COYA 302 Details Frontotemporal dementia	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COYA 302 Details Amyotrophic lateral sclerosis	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.